Australia markets closed

Beijing Balance Medical Technology Co.,Ltd. (688198.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
104.91-2.41 (-2.25%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 14.66B
Enterprise value 14.28B
Trailing P/E 132.49
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)39.14
Price/book (mrq)12.14
Enterprise value/revenue 37.38
Enterprise value/EBITDA 128.41

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 32.32%
S&P500 52-week change 323.23%
52-week high 3144.00
52-week low 397.51
50-day moving average 3110.69
200-day moving average 3122.50

Share statistics

Avg vol (3-month) 3235.01k
Avg vol (10-day) 3198.39k
Shares outstanding 5136.58M
Implied shares outstanding 6136.58M
Float 835.37M
% held by insiders 174.17%
% held by institutions 110.54%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.75%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 30.75%
5-year average dividend yield 4N/A
Payout ratio 461.73%
Dividend date 3N/A
Ex-dividend date 428 May 2024
Last split factor 21.4:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 29.27%
Operating margin (ttm)-2.85%

Management effectiveness

Return on assets (ttm)4.37%
Return on equity (ttm)8.79%

Income statement

Revenue (ttm)382.01M
Revenue per share (ttm)2.77
Quarterly revenue growth (yoy)17.50%
Gross profit (ttm)N/A
EBITDA 99.52M
Net income avi to common (ttm)111.83M
Diluted EPS (ttm)0.80
Quarterly earnings growth (yoy)-28.90%

Balance sheet

Total cash (mrq)447.92M
Total cash per share (mrq)3.28
Total debt (mrq)11.3M
Total debt/equity (mrq)0.94%
Current ratio (mrq)10.47
Book value per share (mrq)8.84

Cash flow statement

Operating cash flow (ttm)111.65M
Levered free cash flow (ttm)-80.58M